arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ROCKWELL MEDICAL, INC.

RMTI
$7.67 ▼ -0.43 (-5.31%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
18 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
32
Health
Poor
Bearish
auto_awesome

Analytical Summary

ROCKWELL MEDICAL, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $275.9M
Dividend Yield —
Revenue Growth -31.8% ↘
Op. Margin -6.8% ↘
ROIC -10.2% ↘
FCF / Share $-0.02 ↘
Trailing P/E —
Price / Book 8.2x
FCF Yield —
Debt / Equity 0.24
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$69.26M
↓ -31.8% —
Net Income Profit after all expenses
$-5.31M
↓ -1007.1% —
Operating Margin Operating profit as % of sales
-6.8%
↓ -1230.6% 18th
FCF / Share Free cash flow per share
$-0.02
↓ -113.5% —
Long-Term Debt Long-term obligations
$8.83M
↑ +4.2% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
20
Returns ↑
31
Financial Health →
52
Cash Quality ↓
26

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters